Articles from Hua Medicine

Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin

By Hua Medicine · Via ACN Newswire · September 28, 2025

Hua Medicine Announces 2025 Interim Results

By Hua Medicine · Via ACN Newswire · August 28, 2025

Hua Medicine Announces 2024 Annual Results

By Hua Medicine · Via ACN Newswire · March 28, 2025

Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce

By Hua Medicine · Via ACN Newswire · March 18, 2025

Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'

By Hua Medicine · Via ACN Newswire · October 24, 2024

Hua Medicine Announces 2021 Annual Results

By Hua Medicine · Via ACN Newswire · March 17, 2022

Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin

By Hua Medicine · Via ACN Newswire · September 26, 2021

Hua and Sinopharm Announced Supply Chain Strategic Cooperation

By Hua Medicine · Via ACN Newswire · September 15, 2021

Hua Medicine Announces 2020 Interim Results

By Hua Medicine · Via ACN Newswire · August 19, 2021

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

By Hua Medicine · Via ACN Newswire · April 23, 2021